MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CLYM — Climb Bio, Inc. Common Stock
NasdaqClimb Bio, Inc. Common Stock
$10.94
-0.13(-1.17%)
- O
- 11.29
- H
- 11.29
- L
- 10.73
- V
- 1.57M
⏱️ End-of-day dataAs of Oct 2, 2026
CLYM — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | 8,356.00 | 35,685.00 | 25,803.00 | 22,682.00 | N/A | N/A |
| Other Short Term Investments | 101,208.00 | 65,395.00 | 61,098.00 | 62,021.00 | N/A | N/A |
| Prepaid Assets | 3,840.00 | 4,769.00 | 4,063.00 | 2,681.00 | N/A | N/A |
| Total Current Assets | 113,404.00 | 105,849.00 | 90,964.00 | 87,384.00 | N/A | N/A |
| Properties | 697.00 | 793.00 | 880.00 | 932.00 | N/A | N/A |
| Investments And Advances | 36,741.00 | 59,572.00 | 88,930.00 | 102,702.00 | N/A | N/A |
| Other Non Current Assets | 1,530.00 | 1,530.00 | 1,530.00 | 1,368.00 | N/A | N/A |
| Total Non Current Assets | 38,968.00 | 61,895.00 | 91,340.00 | 105,002.00 | N/A | N/A |
| Total Assets | 152,372.00 | 167,744.00 | 182,304.00 | 192,386.00 | N/A | N/A |
| Accounts Payable | 860.00 | 2,269.00 | 477.00 | 946.00 | N/A | N/A |
| Accrued Expenses | 2,835.00 | 4,400.00 | 4,167.00 | 5,000.00 | N/A | N/A |
| Short Term Debt | 263.00 | 256.00 | 228.00 | 222.00 | N/A | N/A |
| Other Current Liabilities | 113.00 | 59.00 | 77.00 | 37.00 | N/A | N/A |
| Total Current Liabilities | 4,071.00 | 6,984.00 | 4,949.00 | 6,205.00 | N/A | N/A |
| Long Term Debt | 216.00 | 285.00 | 352.00 | 417.00 | N/A | N/A |
| Total Non Current Liabilities | 216.00 | 285.00 | 352.00 | 417.00 | N/A | N/A |
| Total Liabilities | 4,287.00 | 7,269.00 | 5,301.00 | 6,622.00 | N/A | N/A |
| Common Stock | 5.00 | 5.00 | 7.00 | 7.00 | 7.00 | 7.00 |
| Retained Earnings | -303,449.00 | -289,727.00 | -272,211.00 | -259,323.00 | N/A | N/A |
| Other Shareholders Equity | 157.00 | 435.00 | 469.00 | 318.00 | N/A | N/A |
| Total Shareholders Equity | 148,085.00 | 160,475.00 | 177,003.00 | 185,764.00 | N/A | N/A |
| Additional Paid In Capital | 451,372.00 | 449,762.00 | 448,738.00 | 444,762.00 | N/A | N/A |
| Cash Equivalents | N/A | 35,685.00 | N/A | N/A | N/A | N/A |